Literature DB >> 7874896

Multiple organ failure after liver transplantation.

T B Spanier1, R D Klein, S A Nasraway, W M Rand, R J Rohrer, R B Freeman, S D Schwaitzberg.   

Abstract

OBJECTIVE: To examine the effect of multiple organ failure after liver transplantation on mortality and resource utilization.
DESIGN: Retrospective cohort study.
SETTING: Surgical intensive care unit in a tertiary care university hospital. PATIENTS: Consecutive series of 113 adults undergoing liver transplantation between 1984 and 1992. Patients were excluded if they died intraoperatively (n = 2), required retransplantation (n = 8), or had incomplete records (n = 7).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We prospectively developed definitions for organ failure, and quantitated the frequency and related outcomes for mortality and resource utilization. Multiple organ failure was defined as the presence of two or more organ failures. Patients were grouped according to the presence (n = 31) or absence (n = 65) of multiple organ failure. Preoperative severity of illness was assessed by the Acute Physiology and Chronic Health Evaluation (APACHE II) and United Network for Organ Sharing (UNOS) scoring systems. Postoperative outcome data, including hospital survival rate, hospital length of stay, and charges were recorded. The frequency of multiple organ failure after liver transplantation was 32%. The mortality rate in the patients who developed multiple organ failure was 42% vs. only 2% in those patients without multiple organ failure (p < .0001). Patients with four or more organ failures had a 100% mortality rate. Postoperative multiple organ failure was associated with increased hospital length of stay (46 +/- 7 days vs. 29 +/- 2 days; p = .026) and increased hospital charges ($271,497 +/- 29,994 vs. $136,372 +/- 8,310; p < .0001). Higher preoperative APACHE II and UNOS scores predicted postoperative multiple organ failure, but were less accurate tools for predicting risk of death.
CONCLUSIONS: Multiple organ failure is associated with death and increased resource utilization in liver transplantation. Pretransplantation severity of illness, as measured by APACHE II and UNOS scoring systems, is an important determinant of postoperative multiple organ failure and outcome.

Entities:  

Mesh:

Year:  1995        PMID: 7874896     DOI: 10.1097/00003246-199503000-00009

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Multivariate regression analysis on early mortality after orthotopic liver transplantation.

Authors:  Ye-Ben Qian; Gui-Hua Cheng; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Epidemiology and peculiarities of pediatric multiple organ dysfunction syndrome in New Delhi, India.

Authors:  Praveen Khilnani; Devajit Sarma; Jerry Zimmerman
Journal:  Intensive Care Med       Date:  2006-09-15       Impact factor: 17.440

3.  Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States.

Authors:  John E Scarborough; Ricardo Pietrobon; Carlos E Marroquin; Janet E Tuttle-Newhall; Paul C Kuo; Bradley H Collins; Dev M Desai; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

4.  A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease.

Authors:  P Ricci; T M Therneau; M Malinchoc; J T Benson; J L Petz; G B Klintmalm; J S Crippin; R H Wiesner; J L Steers; J Rakela; T E Starzl; E R Dickson
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

Review 5.  Transjugular Intrahepatic Portosystemic Shunt before and after Liver Transplantation.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

6.  New era of liver transplantation for hepatitis B: a 17-year single-center experience.

Authors:  Dean M Anselmo; Rafik M Ghobrial; Lee Chan Jung; Michael Weaver; Carlos Cao; Sammy Saab; Greg Kunder; Pauline W Chen; Douglas G Farmer; Hasan Yersiz; Angeles Baquerizo; Sunil Geevarghese; Steven H Han; Leonard Goldstein; Curtis D Holt; Jeffrey A Gornbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

7.  A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.

Authors:  R M Ghobrial; R Steadman; J Gornbein; C Lassman; C D Holt; P Chen; D G Farmer; H Yersiz; N Danino; E Collisson; A Baquarizo; S S Han; S Saab; L I Goldstein; J A Donovan; K Esrason; R W Busuttil
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

8.  Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients.

Authors:  R M Ghobrial; H Yersiz; D G Farmer; F Amersi; J Goss; P Chen; S Dawson; S Lerner; N Nissen; D Imagawa; S Colquhoun; W Arnout; S V McDiarmid; R W Busuttil
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

9.  Is SAPS 3 better than APACHE II at predicting mortality in critically ill transplant patients?

Authors:  Vanessa M de Oliveira; Janete S Brauner; Edison Rodrigues Filho; Ruth G A Susin; Viviane Draghetti; Simone T Bolzan; Silvia R R Vieira
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.